⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1272132 | 0.79 | — | — | |
| SCHEMBL432519 | 0.73 | ALDH1A1 (0.36) | — | |
| SCHEMBL13530904 | 0.71 | — | — | |
| SCHEMBL30593075 | 0.69 | — | — | |
| SCHEMBL8680394 | 0.68 | — | — | |
| SCHEMBL5552740 | 0.67 | — | — | |
| SCHEMBL1271479 | 0.65 | — | — | |
| SCHEMBL25435787 | 0.62 | TSHR (0.54) | — | |
| SCHEMBL37351 | 0.62 | TSHR (0.54) | — | |
| SCHEMBL374667 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240083922-A1 | Proteasome Inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2024-03-14 | — | — | US | disclosed |
| US-20230265110-A1 | Proteasome Inhibitors | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20220251117-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2022-08-11 | — | — | US | disclosed |
| US-20220017542-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2022-01-20 | — | — | US | disclosed |
| US-20210206784-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2021-07-08 | — | — | US | disclosed |
| US-20200407376-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2020-12-31 | — | — | US | disclosed |
| US-20200190118-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. | 2020-06-18 | — | — | US | disclosed |
| US-20190144470-A1 | PROTEASOME INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-05-16 | — | — | US | disclosed |
| US-20180305380-A1 | PROTEASOME INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-10-25 | — | — | US | disclosed |
| US-20180145267-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-24 | — | — | US | disclosed |
| US-20110301124-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-12-08 | — | — | US | disclosed |
| US-8003819-B2 | Proteasome inhibitors | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-08-23 | — | — | US | disclosed |
| US-20100204180-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-08-12 | — | — | US | disclosed |
| EP-2178888-A1 | PROTEASOME INHIBITORS | Millennium Pharmaceuticals, Inc. (US) | 2010-04-28 | — | — | EP | disclosed |
| US-7687662-B2 | e.g. 1-({[(2,3-difluorobenzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acid; anticarcinogenic, antiproliferative agent | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2010-03-30 | — | — | US | disclosed |
| US-20090069171-A1 | Catalysts for olefin polymerization, process for production of the catalysts, and method for preservation thereof | JAPAN POLYPROPYLENE CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| WO-2009020448-A1 | PROTEASOME INHIBITORS | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-02-12 | — | — | WO | disclosed |
| US-20090042836-A1 | e.g. 1-({[(2,3-difluorobenzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acid; anticarcinogenic, antiproliferative agent | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-02-12 | — | — | US | disclosed |
| US-7442830-B1 | Proteasome inhibitors | MILLENIUM PHARMACEUTICALS, INC. (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1881012-A1 | CATALYSTS FOR OLEFIN POLYMERIZATION, PROCESS FOR PRODUCTION OF THE CATALYSTS, AND METHOD FOR PRESERVATION THEREOF | Japan Polypropylene Corporation (JP) | 2008-01-23 | — | — | EP | disclosed |